Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Toyama discloses antiplatelet agents

Jan. 23, 1997

Integrilin scheduled for review

Jan. 16, 1997

New compounds for heparin reversal disclosed by University of Michigan

Jan. 14, 1997

Schering-Plough selects Corvas thrombin inhibitor for development

Jan. 13, 1997

NO donors claimed by Searle for cardiovascular applications

Jan. 13, 1997

Fibrinogen receptor antagonists under development at E. Merck

Jan. 10, 1997

Thrombin-binding anticoagulant disclosed by Japanese scientists

Jan. 10, 1997

Boehringer Mannheim clot-busting drug introduced in first market

Jan. 7, 1997

Thrombolytic agent introduced in Germany

Dec. 31, 1996

BMS describes thrombin-activatable plasminogen activator

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...